Invivyd Inc (IVVD)
2.465
+0.04
(+1.44%)
USD |
NASDAQ |
May 15, 14:40
Invivyd Cash from Operations (Quarterly): -50.21M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -50.21M |
| December 31, 2023 | -59.24M |
| September 30, 2023 | -35.35M |
| June 30, 2023 | -37.39M |
| March 31, 2023 | -41.18M |
| December 31, 2022 | -47.40M |
| September 30, 2022 | -56.14M |
| Date | Value |
|---|---|
| June 30, 2022 | -57.39M |
| March 31, 2022 | -59.05M |
| December 31, 2021 | -73.21M |
| September 30, 2021 | -54.21M |
| June 30, 2021 | -33.57M |
| March 31, 2021 | -23.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-73.21M
Minimum
Dec 2021
-23.74M
Maximum
Mar 2021
-48.32M
Average
-50.21M
Median
Mar 2024
Cash from Operations (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 7.569M |
| Viking Therapeutics Inc | -6.134M |
| Stoke Therapeutics Inc | -24.57M |
| 180 Life Sciences Corp | -2.16M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.14M |
| Cash from Financing (Quarterly) | 39.10M |
| Free Cash Flow | -182.33M |
| Free Cash Flow Per Share (Quarterly) | -0.4355 |
| Free Cash Flow Yield | -66.50% |